Sio Gene Therapies Inc.

OTCPK:SIOX Stock Report

Market Cap: US$34.8m

Sio Gene Therapies Dividend

Dividend criteria checks 0/6

Sio Gene Therapies does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.39
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Can Sio Gene Therapies (NASDAQ:SIOX) Afford To Invest In Growth?

Oct 19
Can Sio Gene Therapies (NASDAQ:SIOX) Afford To Invest In Growth?

Here's Why We're A Bit Worried About Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation

Jun 27
Here's Why We're A Bit Worried About Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation

My Favorite Stock For 2022: Sio Gene Therapies

Dec 27

Sio Gene Therapies: Excellent Data And News Obscured By Officer's Departure

Oct 25

We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely

Sep 28
We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely

Sio Gene Therapies EPS beats by $0.12

Jun 09

Sio Gene Therapies: Gene Therapies For Neurodegeneration

May 28

We Think Sio Gene Therapies (NASDAQ:SIOX) Needs To Drive Business Growth Carefully

May 07
We Think Sio Gene Therapies (NASDAQ:SIOX) Needs To Drive Business Growth Carefully

Have Insiders Been Buying Sio Gene Therapies, Inc. (NASDAQ:SIOX) Shares?

Mar 04
Have Insiders Been Buying Sio Gene Therapies, Inc. (NASDAQ:SIOX) Shares?

Sio Gene Therapies secures $11.6M from sale of Arvelle Therapeutics

Feb 04

What Is The Ownership Structure Like For Sio Gene Therapies, Inc. (NASDAQ:SIOX)?

Jan 28
What Is The Ownership Structure Like For Sio Gene Therapies, Inc. (NASDAQ:SIOX)?

Sio Gene Therapies to sell Arvelle stake to Angelini Pharma

Jan 04

Here's Why We're Watching Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation

Dec 24
Here's Why We're Watching Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation

Sio Gene Therapies soars 45% on positive AXO-AAV-GM1 data in nerve cell disorder

Dec 16

Did Sio Gene Therapies, Inc. (NASDAQ:SIOX) Insiders Buy Up More Shares?

Nov 19
Did Sio Gene Therapies, Inc. (NASDAQ:SIOX) Insiders Buy Up More Shares?

Axovant on go with pivotal study of gene therapy for rare inherited lipid disorders

Nov 09

Axovant sees delayed enrollment in Parkinson’s study with gene therapy

Oct 29

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if SIOX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SIOX's dividend payments have been increasing.


Dividend Yield vs Market

Sio Gene Therapies Dividend Yield vs Market
How does SIOX dividend yield compare to the market?
SegmentDividend Yield
Company (SIOX)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Biotechs)2.9%
Analyst forecast in 3 Years (SIOX)n/a

Notable Dividend: Unable to evaluate SIOX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SIOX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate SIOX's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SIOX has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.